FDA
approval
· 2026-03-23
FDA Approved: MALARONE — Supplemental Application (GlaxoSmithKline LLC)
Summary
The FDA approved a supplemental application for Malarone (atovaquone and proguanil hydrochloride) from GlaxoSmithKline LLC.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for MALARONE (ATOVAQUONE AND PROGUANIL HYDROCHLORIDE)